Rebecca E. Gwilt, Esq. is Co-Founder and Partner at Nixon Gwilt Law. She provides legal, regulatory, and business guidance to health care clients, focused primarily on public and private healthcare reforms (e.g., ACA, HITECH, MACRA, bundling/accountable care), digital healthcare (including mHealth and telemedicine), integrated care, value-based care, fraud and abuse (Stark, Anti-kickback, False Claims, and CMP), and healthcare privacy/security (HIPAA, FERPA, Part 2, GDPR). She also provides corporate and transactional services to healthcare clients, including business formation and dissolution, corporate contracting, licensing, compliance, mergers and acquisitions, and reimbursement. She has a particular interest in serving growing digital healthcare/healthcare technology businesses and clients in the regulated medical cannabis industry.
After graduating from the top-ranked Health Care Law program at the University of Maryland Francis King Carey School of Law, Rebecca served at the Centers for Medicare and Medicaid Services (CMS), where she worked with CMS leadership and the President’s domestic policy counsel to develop Affordable Care Act (ACA) policy, guidance, regulations and technology contracts. Since that time, she has advised hundreds of healthcare industry entrepreneurs and innovators. Her expertise includes deep knowledge of healthcare laws and regulations affecting various stakeholder groups, including large and small employers, healthcare providers, payors, and healthcare software and services vendors. She brings to her clients a functional knowledge of health care policy, regulatory compliance, and law, and is a thought leader regarding the future of public and private health reforms.
Rebecca was appointed by the Governor of Virginia to serve on the Board of Medical Assistance Services, which oversees the Commonwealth’s Medicaid program. She is a member of The American Bar Association, the Virginia Bar Association, and the American Health Lawyers Association. She is also co-founder of the Virginia Cannabis Industry Association. She lives with her husband and three sons in Richmond, VA.
“Post-acute facilities should consider creative arrangements that align incentives with vendors—things like value-based payments and shared savings are not just for ACOs anymore. The new federal AKS safe harbors allow for much more creative pricing among providers and technology vendors,” Gwilt notes.6 May 2021
“There are a lot of exciting innovations out there, but ultimately you should be thinking about tech as an investment that pays dividends, financial or otherwise,” says Gwilt.6 May 2021
"Al tools can range broadly in price. If this technology can keep your patients from being readmitted to the hospital, then there are real financial gains to be had. However, if that’s not your pain point, a technology to help reduce readmissions might not be of value. Maybe what you’re really worried about is fall risk. There are app-based solutions that use AI to predict fall risk to help you direct your attention to the most at-risk patients. Your money might be better spent there,” she explains. “I encourage my clients not to fall into the “bright, shiny object” trap.”6 May 2021